Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
As of May 9, 2024, five stocks in the health care sector could be flashing a real warning…
Edgewise Therapeutics Doses First Patient In Phase 2 CIRRUS-HCM Trial Of EDG-7500 In Obstructive Hypertrophic Cardiomyopathy
Edgewise Therapeutics, Inc., (NASDAQ:EWTX), a leading muscle disease biopharmaceutical company, today announced the dosing of the first patient in the Phase 2 CIRRUS-HCMtrial of EDG-7500. EDG-7500 is a novel oral,
How Is The Market Feeling About Edgewise Therapeutics?
Edgewise Therapeutics’s (NYSE:EWTX) short percent of float has fallen 58.78% since its last report. The company recently reported…
Insiders Buying Edgewise Therapeutics And 2 Other Stocks
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session.
TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.
TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Edgewise Therapeutics (NASDAQ:EWTX) stock moved upwards by 35.8% to $13.15 during Friday’s regular session. The market value…
What’s Going On With Edgewise Therapeutics Stock?
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) shares are trading higher Friday after the company announced the pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday.
Shares of World Acceptance Corporation (NASDAQ: WRLD) rose sharply during Friday’s session following upbeat quarterly results.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Atreca (NASDAQ:BCEL) shares increased by 102.7% to $0.22 during Thursday’s regular session. The company’s market cap stands…
Edgewise Therapeutics Highlights 2023 Accomplishments And Anticipated Milestones For 2024 At The 42nd Annual J.P. Morgan Healthcare Conference
Edgewise Therapeutics, Inc., (NASDAQ:EWTX), a leading muscle disease biopharmaceutical company, will present today at the 42nd Annual J.P. Morgan Healthcare Conference at 10:30 am PT (1:30 pm ET), and a live webcast will